GlassScriptPhysician profile
Sarah C Baker
NPI 1750616074
$903.93
in general payments reported to CMS, 2019-2025
13 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.51 · 2022: $305 · 2023: $160 · 2024: $180 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $185.68 | 2021-2024 | Recarbrio, Dificid, Zerbaxa |
| Glaxosmithkline, LLC. | $167.22 | 2022-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $153.16 | 2022-2024 | Fasenra |
| Amgen INC. | $115.20 | 2022 | |
| Genzyme Corporation | $90.75 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $45.04 | 2025 | Neffy |
| Pharming Healthcare, INC. | $43.37 | 2022-2023 | Ruconest |
| Abbvie INC. | $20.66 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.70 | 2025 | Hyqvia |
| Regeneron Healthcare Solutions, INC. | $18.03 | 2023 | Dupixent |
| Alk-Abello, INC | $17.93 | 2023 | Odactra, Ragwitek, Grastek |
| Vapotherm INC | $15.91 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.